Current Valuation: Synthorx (NASDAQ: THOR)
Synthorx is in the biotechnology industry and trades as part of the healthcare sector. The company CEO is Laura Shawver.
Read more
Synthorx
Wall Street News24
Taking Your Financial Future To New Heights